<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_TrinityCollegeDublin skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:TrinityCollegeDublin</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><NAV class="menu fadeIn"><UL><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Background">
                        Background</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Design">
                        E.artemisia Design</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Results">
                        Results</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Conclusions">
                        Conclusions</A></LI></UL><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Measurement">
                        Interlab</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Part_Collection">
                        Parts</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Timeline">
                        Timeline</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Protocols">
                        Protocols</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Practices">
                        Global Health</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Malaria">
                        Malaria</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/GenderInequality">
                        Gender Inequality</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Children">
                        Children</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Logistics">
                        Logistics</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Future">
                        Future</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Interviews">
                        Interviews</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Team">Team</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Attributions">
                        Attributions</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Outreach">
                        Outreach</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Sponsors">
                        Sponsors</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Gallery">
                        Gallery</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Safety">
                        Safety</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Achievements">
                        Achievements</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/Collaborations">
                        iGEM Academy</A></LI><LI><A href="https://2015.igem.org/Team:TrinityCollegeDublin/CorkiGEM">
                        Cork iGEM</A></LI></NAV><DIV class="standardMargin fadeIn centre"><H1 class="headingOne">E.artemisia</H1><H2>Combating Malaria with Synthetic Biology</H2></DIV><DIV class="container fadeIn"><DIV class="leftContainer">
        One of the deadliest diseases in human history, <B>malaria now claims over 600,000 lives a year</B>. 


Our mission is to investigate the <B>production of affordable antimalarial drugs</B> by the means of synthetic biology. We are working with <B>artemisinic acid producing E.coli cells</B> obtained from Amyris, with the support of Zagaya. 


We have constructed biobricks to take advantage of an <B>alternative pathway in artemesinin synthesis</B>. This pathway allows for the production of <B>dihydroartemisinic acid</B>, a direct precursor to artemisinin. 

This method has the potential for larger and cheaper artemisinin production in the future.
    </DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>